시장보고서
상품코드
1514918

인공관절 감염 치료 시장 : 부문별, 국가 및 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Prosthetic Joint Infection Treatment Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 298 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

인공관절 감염 치료(Prosthetic Joint Infection Treatment) 시장 규모는 2023년 1억 8,878만 달러였으며, 2024년부터 2032년까지 CAGR 4.6%로 추이하며 확대 할 것으로 예상됩니다.

인공 관절 감염 치료 시장-시장 역학

인공 관절 치환술의 보급률 상승과 진단 기술 시장 개척이 시장 수요를 촉진할 것으로 예측됩니다.

세계 인구의 고령화와 라이프 스타일의 변화에 따라 인공 고관절 치환술이나 인공 슬관절 치환술 등의 요구가 높아지고 있으며, 이것이 시장 성장을 뒷받침하고 있습니다. 인공 관절 감염의 만연과 함께 수술 건수가 증가하고 있기 때문에 효과적인 치료 솔루션이 요구되고 있습니다.M 인공 관절 감염은 항생제 내성의 세계 동향의 예외는 아닙니다. 항생제에 내성이 있는 박테리아 균주의 출현은 압박 손상(PJI) 관리에 영향을 미치며 새로운 치료법과 치료 접근법을 창출하고자 합니다.

분자진단 도구와 첨단 영상 진단을 포함한 진단 방법의 발전으로 인공 관절 감염은 더 빠르고 정확하게 발견 될 수 있습니다. 효과적인 치료에 필수적인 조기 발견은 관련 치료법 선택의 필요성에 달려 있습니다. 바이오필름을 표적으로 하는 약물, 항생제로 채워진 뼈 시멘트, 첨단 수술 절차 등 새로운 치료법의 도입으로 인공 관절 감염의 치료 옵션이 늘어났습니다. 이러한 신흥국 시장의 개척은 시장의 확대, 재발률의 저하, 치료 성적의 향상으로 이어질 가능성을 지니고 있습니다. 이러한 요인들이 결합되어 인공관절 감염 치료산업의 확대와 성장을 지원하고 있습니다.

인공 관절 감염 치료 시장-주요 인사이트력

리서치 애널리스트 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 4.6%의 CAGR로 매년 성장할 것으로 예측됩니다.

유형별로, 푸시딘산 부문은 PJI 치료에서 높은 효능으로 2023년에 가장 큰 시장 점유율을 나타낼 것으로 예측됩니다.

용도별로는 임상 운영에 대한 높은 수요로 인해 임상 부문이 2023년의 주요 용도였습니다.

최종 사용자별로 병원에서의 PJI 관련 수술 치료의 높은 보급률로 2023년에는 병원 부문이 주요 최종 사용자였습니다.

지역별로는 북미가 2023년 주요 수익원이었으나 이는 수술 증가와 PJI 치료에 대한 높은 수요 때문입니다.

인공 관절 감염 치료 시장-세분화 분석 :

인공 관절 감염 치료 세계 시장은 유형, 용도, 최종 사용자 및 지역에 따라 구분됩니다.

유형별로는 푸시딘산, 아세트산 레팜린, MTF-101, TNP-2092, 기타. 시장을 독점하는 것은 푸시딘산 부문입니다. 푸시딘산은 PJI 관련 질환의 치료에 높은 효과를 발휘합니다.

용도별로는 임상, 의료 처치, 기타 3개로 분류됩니다. 임상 분야가 시장을 독점하고 있습니다. 정형외과 진료와 인공 관절 치환술의 요구가 증가함에 따라 시장 성장이 뒷받침됩니다.

최종 사용자별로는 병원, 클리닉, 기타로 분류됩니다. 병원 부문은 시장을 독점하고 있으며 예측 기간 동안 높은 우위를 유지할 것으로 예상됩니다. 관절 관련 수술과 정형외과 질환의 높은 보급률이 이 분야의 성장을 뒷받침하고 있습니다.

인공 관절 감염 치료 시장-지리적 통찰

세계적으로, 이 시장은 북미, 남미, 유럽, 아시아 태평양, 중동 및 아프리카으로 퍼져 있습니다. 북미는 인공관절 치환술의 보급률의 높이, 진보된 헬스케어 인프라, 의료기술 혁신에 대한 주력의 강도 등의 요인으로부터 인공관절 감염 치료 시장에 크게 공헌할 것으로 예상됩니다. 특히 미국은 세계 시장에서 큰 점유율을 차지하고 있습니다. 남미는 의료 인프라 개선에 힘입어 PJI 치료의 유망한 시장으로 부상하고 있습니다.

인공 관절 감염 치료 시장-경쟁 구도 :

인공 관절 감염 치료 시장은 소규모 및 대규모 시장 진출 기업으로 구성됩니다. 시장 진출기업은 PJI 치료 솔루션 포트폴리오를 강화하기 위해 R&D에 투자하고 있습니다. 최근의 추세는 감염 위험을 줄이고 환자의 예후를 개선하기 위해 고안된 첨단 임플란트 재료의 도입을 포함합니다. 각 회사는 또한 항균 드레싱 재료, 상처 케어 솔루션, 수술 기구 등 PJI 치료를 위한 광범위한 제품 제공에 주력하고 있습니다.

목차

제1장 인공관절 감염 치료 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 인공관절 감염 치료의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 인공관절 감염 치료 산업 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 프레임워크 분석

제5장 인공관절 감염 치료 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 인공관절 감염 치료 시장 상황

  • 인공관절 감염 치료 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신흥기업 분석

제7장 인공관절 감염 치료 시장-유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 푸시딘산
    • 레팜린 아세테이트
    • MTF-101
    • TNP-2092
    • 기타

제8장 인공관절 감염 치료 시장-용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 임상
    • 의료 처치
    • 기타

제9장 인공관절 감염 치료 시장-최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원
    • 클리닉
    • 기타

제10장 인공관절 감염 치료 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아 태평양
    • 개요
    • 아시아 태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 남미
    • 개요
    • 남미의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석-인공관절 감염 치료 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Zimmer Biomet Holdings, Inc.
    • Stryker Corporation
    • Johnson&Johnson(DePuy Synthes)
    • Smith &Nephew plc
    • Bioventus LLC
    • ConvaTec Group plc
    • Becton, Dickinson and Company
    • Heraeus Holding GmbH
    • Medtronic plc
    • B. Braun Melsungen AG
    • Molnlycke Health Care AB
    • Merck &Co., Inc.
    • Osteal Therapeutics
    • Integra LifeSciences Holdings Corporation
    • Armata Pharmaceuticals
    • Arthrex, Inc.
    • 기타

제12장 애널리스트의 전방위 전망

LYJ

REPORT HIGHLIGHT

Prosthetic Joint Infection Treatment Market size was valued at USD 188.78 Million in 2023, expanding at a CAGR of 4.6% from 2024 to 2032.

Treatment for prosthetic joint infections (PJIs) focuses on controlling infections in artificial joints, like knee or hip replacements. Because of the formation of biofilms, antibiotic resistance, and the possibility of severe consequences from untreated infections, these infections can be difficult to treat. Depending on the specific needs of each patient, treatment plans often combine medicinal and surgical procedures.

Prosthetic Joint Infection Treatment Market- Market Dynamics

The rising prevalence of joint replacement surgeries and the development of diagnostic techniques are expected to propel market demand

There is an increasing need for joint replacement surgery, such as hip and knee replacements, as the world's population ages and leads different lifestyles which is boosting the market growth. Effective treatment solutions are in high demand as the number of surgeries performed is rising along with the prevalence of prosthetic joint infections. Prosthetic joint infections are not an exception to the worldwide trend of antibiotic resistance. The advent of bacterial strains resistant to antibiotics affects the management of pressure injuries (PJIs) and calls for the creation of novel treatments and treatment approaches.

Prosthetic joint infections can now be detected more quickly and accurately thanks to advancements in diagnostic methods including molecular diagnostic tools and sophisticated imaging modalities. The need for related treatment choices might be influenced by early detection, which is essential for effective therapy. There are now more alternatives for treating prosthetic joint infections thanks to the introduction of newer therapeutic methods such as biofilm-targeting drugs, antibiotic-loaded bone cement, and sophisticated surgical techniques. These developments have the potential to boost market expansion, lower recurrence rates, and enhance treatment outcomes. Together, these factors support the expansion and growth of the prosthetic joint infection treatment industry.

Prosthetic Joint Infection Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.6% over the forecast period (2024-2032)

Based on Type segmentation, the fusidic acid segment was predicted to show maximum market share in the year 2023, owing to its high effectiveness in PJI treatment.

Based on Application segmentation, the clinical segment was the leading Application in 2023, due to high demand in clinical operations.

Based on End User segmentation, the hospital segment was the leading End User in 2023, owing to the high prevalence of PJI related surgery treatment at hospitals.

Based on region, North America was the leading revenue generator in 2023, owing to growing surgery & high demand for PJI treatment.

Prosthetic Joint Infection Treatment Market- Segmentation Analysis:

The Global Prosthetic Joint Infection Treatment Market is segmented based on Type, Application, End User, and Region.

The market is divided into five categories based on Type: fusidic acid, Lefamulin acetate, MTF-101, TNP-2092, and others. The fusidic acid segment dominates the market. Fusidic acid is highly effective in treating PJI related disorders.

The market is divided into three categories based on the Application: clinical, medical procedures, and others. The clinical segment dominates the market. The growing need for orthopedic practices, and joint replacement surgeries, is fueling market growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. High prevalence of joint related surgeries, orthopedic surgery disorders are augmenting the segment growth.

Prosthetic Joint Infection Treatment Market- Geographical Insights

Globally, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is expected to be a significant contributor to the PJI treatment market due to factors such as a high prevalence of joint replacement surgeries, advanced healthcare infrastructure, and a strong focus on medical innovation. The United States, in particular, accounts for a substantial share of the global market. Latin America is emerging as a promising market for PJI treatment, supported by improving healthcare infrastructure.

Prosthetic Joint Infection Treatment Market- Competitive Landscape:

The Prosthetic Joint Infection Treatment market is made up of small & large market participants. Market players have been investing in research and development to enhance their portfolio of PJI treatment solutions. Recent developments include the introduction of advanced implant materials designed to reduce the risk of infection and improve patient outcomes. Companies also focus on offering a range of products for PJI treatment, including antimicrobial dressings, wound care solutions, and surgical instruments.

Recent Developments:

In June 2024, Osteal Therapeutics raised USD 50 million in Series D investment, as the orthopedic infection treatment specialist wants to expand their business.

In August 2022, Armata Pharmaceuticals announced approval of its new drug application AP-SA02 in prosthetic joint infection (PJI).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET KEY PLAYERS

  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Smith & Nephew plc
  • Bioventus LLC
  • ConvaTec Group plc
  • Becton, Dickinson and Company
  • Heraeus Holding GmbH
  • Medtronic plc
  • B. Braun Melsungen AG
  • Molnlycke Health Care AB
  • Merck & Co., Inc.
  • Osteal Therapeutics
  • Integra LifeSciences Holdings Corporation
  • Armata Pharmaceuticals
  • Arthrex, Inc.
  • Others

GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Fusidic acid
  • Lefamulin acetate
  • MTF-101
  • TNP-2092
  • Others

GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Clinical
  • Medical procedures
  • Others

GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL PROSTHETIC JOINT INFECTION TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Prosthetic Joint Infection Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Prosthetic Joint Infection Treatment Market Snippet by Type
    • 2.1.2. Prosthetic Joint Infection Treatment Market Snippet by Application
    • 2.1.3. Prosthetic Joint Infection Treatment Market Snippet by End User
    • 2.1.4. Prosthetic Joint Infection Treatment Market Snippet by Country
    • 2.1.5. Prosthetic Joint Infection Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Prosthetic Joint Infection Treatment Key Market Trends

  • 3.1. Prosthetic Joint Infection Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Prosthetic Joint Infection Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Prosthetic Joint Infection Treatment Market Opportunities
  • 3.4. Prosthetic Joint Infection Treatment Market Future Trends

4. Prosthetic Joint Infection Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Prosthetic Joint Infection Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Prosthetic Joint Infection Treatment Market Landscape

  • 6.1. Prosthetic Joint Infection Treatment Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Prosthetic Joint Infection Treatment Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Fusidic acid
    • 7.1.3. Lefamulin acetate
    • 7.1.4. MTF-101
    • 7.1.5. TNP-2092
    • 7.1.6. Others

8. Prosthetic Joint Infection Treatment Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Clinical
    • 8.1.3. Medical procedures
    • 8.1.4. Others

9. Prosthetic Joint Infection Treatment Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Prosthetic Joint Infection Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Prosthetic Joint Infection Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Prosthetic Joint Infection Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Prosthetic Joint Infection Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Prosthetic Joint Infection Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Prosthetic Joint Infection Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Prosthetic Joint Infection Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Zimmer Biomet Holdings, Inc.
    • 11.2.2. Stryker Corporation
    • 11.2.3. Johnson & Johnson (DePuy Synthes)
    • 11.2.4. Smith & Nephew plc
    • 11.2.5. Bioventus LLC
    • 11.2.6. ConvaTec Group plc
    • 11.2.7. Becton, Dickinson and Company
    • 11.2.8. Heraeus Holding GmbH
    • 11.2.9. Medtronic plc
    • 11.2.10. B. Braun Melsungen AG
    • 11.2.11. Molnlycke Health Care AB
    • 11.2.12. Merck & Co., Inc.
    • 11.2.13. Osteal Therapeutics
    • 11.2.14. Integra LifeSciences Holdings Corporation
    • 11.2.15. Armata Pharmaceuticals
    • 11.2.16. Arthrex, Inc.
    • 11.2.17. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제